MedTrace Logo

Safety and Efficacy of 7-day Wear Infusion Set vs. Control Infusion Set.

NCT04208282 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2020-05-05

No results posted yet for this study

Summary

The purpose of this study is to evaluate the Extended Wear (EW) infusion set seven day functioning in patients with Type 1 diabetes compared to the Quick-set infusion set. The study will be carried out in adults with type 1 diabetes.

Conditions

  • Type1diabetes

Interventions

DEVICE

7 day infusion set

7 days survival of the sets

Sponsors & Collaborators

  • Medtronic

    collaborator INDUSTRY

  • Sheba Medical Center

    lead OTHER_GOV

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-07-01
Primary Completion
2020-03-30
Completion
2020-03-31

Countries

  • Israel

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04208282 on ClinicalTrials.gov